Chargement en cours...
Alterations of tumor microenvironment by nitric oxide impedes castration-resistant prostate cancer growth
Immune targeted therapy of nitric oxide (NO) synthases are being considered as a potential frontline therapeutic to treat patients diagnosed with locally advanced and metastatic prostate cancer. However, the role of NO in castration-resistant prostate cancer (CRPC) is controversial because NO can in...
Enregistré dans:
| Publié dans: | Proc Natl Acad Sci U S A |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
National Academy of Sciences
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6217394/ https://ncbi.nlm.nih.gov/pubmed/30322928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1812704115 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|